271 related articles for article (PubMed ID: 7693535)
1. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine.
Dirnhofer S; Klieber R; De Leeuw R; Bidart JM; Merz WE; Wick G; Berger P
FASEB J; 1993 Nov; 7(14):1381-5. PubMed ID: 7693535
[TBL] [Abstract][Full Text] [Related]
2. Phase I clinical trial of a World Health Organisation birth control vaccine.
Jones WR; Bradley J; Judd SJ; Denholm EH; Ing RM; Mueller UW; Powell J; Griffin PD; Stevens VC
Lancet; 1988 Jun; 1(8598):1295-8. PubMed ID: 2453766
[TBL] [Abstract][Full Text] [Related]
3. Immunobiological properties of a carboxy-terminal 53-amino acid peptide of the beta subunit of human chorionic gonadotropin.
Sahal D; Ramakrishnan S; Iyer KS; Das C; Talwar GP
J Reprod Immunol; 1982 Jul; 4(3):145-50. PubMed ID: 6181254
[TBL] [Abstract][Full Text] [Related]
4. Development, characterization, and application of monoclonal antibodies to the native and synthetic beta COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG.
Krichevsky A; Birken S; O'Connor J; Acevedo HF; Bikel K; Lustbader J; Hartree A; Canfield RE
Endocrinology; 1994 Mar; 134(3):1139-45. PubMed ID: 7509735
[TBL] [Abstract][Full Text] [Related]
5. Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG.
Furuhashi M; Shikone T; Fares FA; Sugahara T; Hsueh AJ; Boime I
Mol Endocrinol; 1995 Jan; 9(1):54-63. PubMed ID: 7539107
[TBL] [Abstract][Full Text] [Related]
6. Antibody response against three epitopic domains on human chorionic gonadotropin (hCG) in women and rodents immunized with a beta hCG-based immunocontraceptive vaccine.
Deshmukh US; Talwar GP; Gupta SK
J Clin Immunol; 1994 May; 14(3):162-8. PubMed ID: 7523433
[TBL] [Abstract][Full Text] [Related]
7. Antibody binding to the beta-subunit of deglycosylated chorionic gonadotropin converts the antagonist to an agonist.
Rebois RV; Liss MT
J Biol Chem; 1987 Mar; 262(8):3891-6. PubMed ID: 2434506
[TBL] [Abstract][Full Text] [Related]
8. Anti-hCG vaccines are in clinical trials.
Talwar GP; Singh O; Pal R; Chatterjee N
Scand J Immunol Suppl; 1992; 11():123-6. PubMed ID: 1514026
[TBL] [Abstract][Full Text] [Related]
9. The immune response to a synthetic peptide analogous to the 109-145 beta hCG carboxyl-terminus is directed against two major and two minor regions.
Bidart JM; Bellet DH; Alberici GF; Van Besien F; Bohuon C
Mol Immunol; 1987 Apr; 24(4):339-45. PubMed ID: 2443832
[TBL] [Abstract][Full Text] [Related]
10. [Antigenic determinants of human chorionic gonadotropin (hCG): identification of epitopes and determination of their biological functions, for use in immunometric test systems and development of a fertility regulating vaccine].
Dirnhofer S; Gerth R; Madersbacher S; Wick G; Berger P
Wien Klin Wochenschr; 1993; 105(11):314-9. PubMed ID: 7687404
[TBL] [Abstract][Full Text] [Related]
11. Vaccines for control of fertility and hormone dependent cancers.
Talwar GP; Singh O; Pal R; Chatterjee N
Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
Talwar GP; Singh O; Singh V; Rao DN; Sharma NC; Das C; Rao LV
Fertil Steril; 1986 Jul; 46(1):120-6. PubMed ID: 2424791
[TBL] [Abstract][Full Text] [Related]
13. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
Bidart JM; Ozturk M; Bellet DH; Jolivet M; Gras-Masse H; Troalen F; Bohuon CJ; Wands JR
J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
[TBL] [Abstract][Full Text] [Related]
14. Relative location of epitopes involved in synergistic antibody binding using human chorionic gonadotropin as a model.
Klonisch T; Delves PJ; Berger P; Panayotou G; Lapthorn AJ; Isaacs NW; Wick G; Lund T; Roitt IM
Eur J Immunol; 1996 Aug; 26(8):1897-905. PubMed ID: 8765037
[TBL] [Abstract][Full Text] [Related]
15. Anti-fertility vaccines.
Talwar GP; Raghupathy R
Vaccine; 1989 Apr; 7(2):97-101. PubMed ID: 2665354
[TBL] [Abstract][Full Text] [Related]
16. Detection of conformational changes in human chorionic gonadotropin upon binding to rat gonadal receptors.
Moyle WR; Pressey A; Dean-Emig D; Anderson DM; Demeter M; Lustbader J; Ehrlich P
J Biol Chem; 1987 Dec; 262(35):16920-6. PubMed ID: 3680278
[TBL] [Abstract][Full Text] [Related]
17. Probing the receptor-interaction of glycoprotein hormones with monoclonal antibodies.
Schwarz S; Berger P; Nelboeck E; Khashabi D; Panmoung W; Klieber R; Wick G
J Recept Res; 1988; 8(1-4):437-53. PubMed ID: 2455048
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis for epitopes on the free beta-subunit of human chorionic gonadotrophin (hCG), its carboxyl-terminal peptide and the hCG beta-core fragment.
Dirnhofer S; Madersbacher S; Bidart JM; Ten Kortenaar PB; Spöttl G; Mann K; Wick G; Berger P
J Endocrinol; 1994 Apr; 141(1):153-62. PubMed ID: 7516961
[TBL] [Abstract][Full Text] [Related]
19. A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
Schutze MP; LeClerc C; Jolivet M; Deriaud E; Audibert F; Chang CC; Chedid L
Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):84-90. PubMed ID: 2445212
[TBL] [Abstract][Full Text] [Related]
20. Use of synthetic peptides as immunogens for developing a vaccine against human chorionic gonadotropin.
Stevens VC
Ciba Found Symp; 1986; 119():200-25. PubMed ID: 2426053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
